Published in Mol Cell Proteomics on October 20, 2010
Quantitative proteomics targeting classes of motif-containing peptides using immunoaffinity-based mass spectrometry. Mol Cell Proteomics (2012) 1.07
Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors. J Biol Chem (2012) 0.96
Peptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification. Clin Lab Med (2011) 0.91
Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry. Proteomics (2012) 0.90
Epitope-specificity of recombinant antibodies reveals promiscuous peptide-binding properties. Protein Sci (2012) 0.84
Indirect protein quantification of drug-transforming enzymes using peptide group-specific immunoaffinity enrichment and mass spectrometry. Sci Rep (2015) 0.77
A peptide mimic blocks the cross-reaction of anti-DNA antibodies with glomerular antigens. Clin Exp Immunol (2015) 0.76
Combining ultracentrifugation and peptide termini group-specific immunoprecipitation for multiplex plasma protein analysis. Mol Cell Proteomics (2012) 0.75
Specific affinity enrichment of electrochemically cleaved peptides based on Cu (II)-mediated spirolactone tagging. Anal Chem (2017) 0.75
Mass spectrometry-based proteomics. Nature (2003) 28.94
Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol (2001) 28.01
Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science (2009) 20.49
Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell (2009) 18.31
Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell (2006) 11.38
Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell (2002) 10.34
Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics (2005) 8.92
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol (2004) 7.69
Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics (2007) 6.96
PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows. EMBO Rep (2008) 6.10
Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). J Proteome Res (2004) 5.57
Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol (2000) 5.55
Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci U S A (2000) 4.79
A human proteome detection and quantitation project. Mol Cell Proteomics (2009) 2.80
Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal Biochem (2006) 2.55
An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol Cell Proteomics (2009) 2.40
Phosphoproteomic approaches to elucidate cellular signaling networks. Curr Opin Biotechnol (2006) 1.60
The Wnt connection to tumorigenesis. Int J Dev Biol (2004) 1.53
Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics. Int J Cancer (2005) 1.48
The PeptideAtlas Project. Methods Mol Biol (2010) 1.46
Tyrosine phosphorylation mapping of the epidermal growth factor receptor signaling pathway. J Biol Chem (2001) 1.37
The catenin family at a glance. J Cell Sci (2010) 1.24
Using the global proteome machine for protein identification. Methods Mol Biol (2006) 1.22
Affinity separation and enrichment methods in proteomic analysis. J Proteomics (2008) 1.12
Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosis. Proteomics Clin Appl (2007) 1.08
Affinity prefractionation for MS-based plasma proteomics. Proteomics (2009) 1.07
CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans. Int J Mol Med (2007) 0.92
Strategy for surveying the proteome using affinity proteomics and mass spectrometry. Proteomics (2009) 0.90
Proteome wide screening using peptide affinity capture. Proteomics (2009) 0.89
Protein microarrays for antibody profiling: specificity and affinity determination on a chip. Proteomics (2005) 0.89
Optimal selection of epitopes for TXP-immunoaffinity mass spectrometry. Algorithms Mol Biol (2010) 0.85
Functional peptide arrays for high-throughput chemical biology based applications. Curr Opin Biotechnol (2007) 0.79
An effective and rapid method for functional characterization of immunoadsorbents using POROS beads and flow cytometry. J Proteome Res (2004) 0.78
Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem (2005) 4.18
ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods (2007) 2.04
Expanding assay dynamics: a combined competitive and direct assay system for the quantification of proteins in multiplexed immunoassays. Clin Chem (2008) 1.97
JSBML: a flexible Java library for working with SBML. Bioinformatics (2011) 1.73
SBMLsqueezer: a CellDesigner plug-in to generate kinetic rate equations for biochemical networks. BMC Syst Biol (2008) 1.71
A designed ankyrin repeat protein evolved to picomolar affinity to Her2. J Mol Biol (2007) 1.71
Protein microarray technology. Trends Biotechnol (2002) 1.68
Mass spectrometric analysis of surfactant metabolism in human volunteers using deuteriated choline. Am J Respir Crit Care Med (2004) 1.51
KEGGtranslator: visualizing and converting the KEGG PATHWAY database to various formats. Bioinformatics (2011) 1.46
Protein microarrays for diagnostic assays. Anal Bioanal Chem (2008) 1.35
EDISA: extracting biclusters from multiple time-series of gene expression profiles. BMC Bioinformatics (2007) 1.31
Path2Models: large-scale generation of computational models from biochemical pathway maps. BMC Syst Biol (2013) 1.29
Protein microarrays: promising tools for proteomic research. Proteomics (2003) 1.27
A biomarker panel to discriminate between systemic inflammatory response syndrome and sepsis and sepsis severity. J Emerg Trauma Shock (2010) 1.25
Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans. Cytokine (2008) 1.25
SBML2L(A)T(E)X: conversion of SBML files into human-readable reports. Bioinformatics (2009) 1.24
Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. Clin Chem (2013) 1.24
Protein microarray technology. Drug Discov Today (2002) 1.23
Precise generation of systems biology models from KEGG pathways. BMC Syst Biol (2013) 1.11
Protein microarrays: applications and future challenges. Curr Opin Drug Discov Devel (2005) 1.10
Protein microarrays and multiplexed sandwich immunoassays: what beats the beads? Comb Chem High Throughput Screen (2004) 1.07
Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. Invest Ophthalmol Vis Sci (2005) 1.06
Suspension microarrays for the identification of the response patterns in hyperinflammatory diseases. Med Eng Phys (2008) 1.05
Loss of mitochondrial peptidase Clpp leads to infertility, hearing loss plus growth retardation via accumulation of CLPX, mtDNA and inflammatory factors. Hum Mol Genet (2013) 1.03
Optimal assignment methods for ligand-based virtual screening. J Cheminform (2009) 1.03
Protein microarrays for personalized medicine. Clin Chem (2010) 1.03
TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR. Nucleic Acids Res (2011) 1.01
Sequential multiplex analyte capturing for phosphoprotein profiling. Mol Cell Proteomics (2010) 0.99
Modeling metabolic networks in C. glutamicum: a comparison of rate laws in combination with various parameter optimization strategies. BMC Syst Biol (2009) 0.99
Qualitative translation of relations from BioPAX to SBML qual. Bioinformatics (2012) 0.98
jCompoundMapper: An open source Java library and command-line tool for chemical fingerprints. J Cheminform (2011) 0.98
Automated label-free quantification of metabolites from liquid chromatography-mass spectrometry data. Mol Cell Proteomics (2013) 0.98
Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection. BMC Cancer (2009) 0.96
Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors. J Biol Chem (2012) 0.96
A generic operational strategy to qualify translational safety biomarkers. Drug Discov Today (2011) 0.94
Multiplex microsphere-based flow cytometric platforms for protein analysis and their application in clinical proteomics - from assays to results. Electrophoresis (2009) 0.94
Protein microarrays: catching the proteome. Mech Ageing Dev (2005) 0.94
Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients. Biomarkers (2008) 0.93
Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion. Toxicol Sci (2012) 0.92
Characterization and functional analysis of osteoblast-derived fibulins in the human hematopoietic stem cell niche. Exp Hematol (2008) 0.92
Interpreting linear support vector machine models with heat map molecule coloring. J Cheminform (2011) 0.91
Microsphere-based co-immunoprecipitation in multiplex. Anal Biochem (2009) 0.91
Miniaturised multiplexed immunoassays. Curr Opin Chem Biol (2002) 0.91
Protein microarray technology. Front Biosci (2002) 0.90
A dual array-based approach to assess the abundance and posttranslational modification state of signaling proteins. Sci Signal (2012) 0.90
Ha-ras and β-catenin oncoproteins orchestrate metabolic programs in mouse liver tumors. Int J Cancer (2014) 0.89
Proteome wide screening using peptide affinity capture. Proteomics (2009) 0.89
A comprehensive small interfering RNA screen identifies signaling pathways required for gephyrin clustering. J Neurosci (2012) 0.89
Protein microarrays for antibody profiling: specificity and affinity determination on a chip. Proteomics (2005) 0.89
Use of support vector machines for disease risk prediction in genome-wide association studies: concerns and opportunities. Hum Mutat (2012) 0.89
Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia. BMC Cancer (2012) 0.89
Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care (2013) 0.88
Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes. Am J Pathol (2006) 0.88
The systems biology simulation core algorithm. BMC Syst Biol (2013) 0.88
Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer. Anal Chim Acta (2008) 0.88
MicroPrep: chip-based dielectrophoretic purification of mitochondria. Electrophoresis (2010) 0.88
Secretion of matrix metalloproteinase 3 by expanded articular chondrocytes as a predictor of ectopic cartilage formation capacity in vivo. Arthritis Rheum (2008) 0.88
Five years later: the current status of the use of proteomics and transcriptomics in EMF research. Proteomics (2012) 0.87
Atomic local neighborhood flexibility incorporation into a structured similarity measure for QSAR. J Chem Inf Model (2009) 0.87
Multiplexed immunoassays for the analysis of breast cancer biopsies. Anal Bioanal Chem (2010) 0.86
Applicability of different hydraulic parameters to describe soil detachment in eroding rills. PLoS One (2013) 0.86
Screening for protein-DNA interactions by automatable DNA-protein interaction ELISA. PLoS One (2013) 0.86
Linking the epigenome to the genome: correlation of different features to DNA methylation of CpG islands. PLoS One (2012) 0.85
Miniaturized parallelized sandwich immunoassays. Methods Mol Biol (2008) 0.85
Novel functional profiling approach combining reverse phase protein microarrays and human 3-D ex vivo tissue cultures: expression of apoptosis-related proteins in human colon cancer. Proteomics (2009) 0.85
Optimal selection of epitopes for TXP-immunoaffinity mass spectrometry. Algorithms Mol Biol (2010) 0.85
BowTieBuilder: modeling signal transduction pathways. BMC Syst Biol (2009) 0.84
Conditional disruption of Axin1 leads to development of liver tumors in mice. Gastroenterology (2012) 0.84
Plasma phosphatidylcholine alterations in cystic fibrosis patients: impaired metabolism and correlation with lung function and inflammation. Cell Physiol Biochem (2015) 0.84
From spots to beads-PTM-peptide bead arrays for the characterization of anti-histone antibodies. Proteomics (2013) 0.84
µFBI: a microfluidic bead-based immunoassay for multiplexed detection of proteins from a µL sample volume. PLoS One (2010) 0.84